Tarsons Products Limited (TARSONS) AI Stock Analysis

• Market Cap: ₹9.70B
• Dividend Yield: 0.86%
• Average Volume (3M): 2.32K
• Price to Earnings (P/E): 61.6
• Beta (1Y): 0.73
• Revenue Growth: 14.37%
• EPS Growth: -40.47%
• Country: IN
• Employees: 823
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Medical - Instruments & Supplies
• EPS (TTM): 0.50
• Shares Outstanding: 53,206,280
• 10 Day Avg. Volume: 1,556
• 30 Day Avg. Volume: 2,322
• PEG Ratio: -2.10
• Price to Book (P/B): 2.99
• Price to Sales (P/S): 4.79
• P/FCF Ratio: -34.16
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 11.7
• Revenue Forecast (FY): ₹4.88B

• Rating: 55 Neutral
• Price Target: ₹187.00 ▼(-18.78% Downside)
• Action: Reiterated Date: 11/26/25
• Date: Action: Reiterated 11/26/25

Tarsons Products Limited shows strong revenue growth and operational efficiency, but faces significant challenges in profitability and free cash flow generation. The technical analysis indicates bearish momentum, with the stock trading below major moving averages and showing oversold conditions. Additionally, the high P/E ratio suggests overvaluation, while the low dividend yield offers limited income potential. These factors collectively contribute to a moderate overall stock score.

Positive Factors

Recurring consumables business model

A core consumables business creates recurring, repeatable demand from research, diagnostics and industrial labs. Combined with a broad product catalogue and in-house manufacturing, this supports durable revenue visibility, higher wallet share per customer and margin capture across cycles.

Negative Factors

Negative free cash flow

Negative free cash flow in 2025 and declining FCF growth constrain financial flexibility for capex, expansion, debt reduction or shareholder returns. Persistent FCF shortfalls can force external financing, slow strategic investments, and increase liquidity risk over the medium term.

Tarsons Products Limited Business Overview & Revenue Model

Company Description

Tarsons Products Limited engages in the manufacturing and trading of plastic laboratory products and scientific instruments in India and internationally. The company's products include disposable plastic labware, centrifuge ware, cryo labware, liq...

Read more

Tarsons Products Limited engages in the manufacturing and trading of plastic laboratory products and scientific instruments in India and internationally. The company's products include disposable plastic labware, centrifuge ware, cryo labware, liq...

How the Company Makes Money

Tarsons makes money primarily by manufacturing and selling laboratory consumables (recurring-use products that need frequent replacement) to end customers such as research institutes, hospitals/diagnostic labs, pharmaceutical and biotech companies...

Read more

Tarsons makes money primarily by manufacturing and selling laboratory consumables (recurring-use products that need frequent replacement) to end customers such as research institutes, hospitals/diagnostic labs, pharmaceutical and biotech companies...

Tarsons Products Limited Financial Statement Overview

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	4.02B	3.92B	2.96B	2.83B	3.01B	2.28B
Gross Profit	1.93B	1.35B	985.42M	2.18B	1.49B	1.54B
EBITDA	1.33B	1.27B	1.11B	1.42B	1.61B	1.09B
Net Income	205.67M	297.70M	426.40M	807.14M	1.01B	688.70M
Balance Sheet
Total Assets	11.64B	10.80B	9.72B	7.26B	5.44B	2.96B
Cash, Cash Equivalents and Short-Term Investments	313.56M	256.52M	226.11M	590.58M	774.42M	23.32M
Total Debt	3.96B	3.39B	2.69B	1.11B	216.65M	335.01M
Total Liabilities	5.37B	4.50B	3.59B	1.56B	543.96M	516.12M
Stockholders Equity	6.27B	6.30B	6.13B	5.69B	4.90B	2.44B
Cash Flow
Free Cash Flow	-267.75M	-550.87M	-816.28M	-1.14B	-485.02M	38.33M
Operating Cash Flow	444.51M	966.20M	1.03B	755.99M	834.67M	681.55M
Investing Cash Flow	-783.05M	-1.47B	-2.85B	-1.79B	-1.38B	-639.11M
Financing Cash Flow	321.34M	578.12M	1.36B	845.61M	1.30B	-272.23M

Tarsons Products Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 230.25
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:TARSONS, the sentiment is Negative. The current price of 230.25 is above the 20-day moving average (MA) of 186.22, above the 50-day MA of 194.44, and below the 200-day MA of 276.19, indicating a bearish trend. The MACD of -5.44 indicates Positive momentum. The RSI at 45.70 is Neutral, neither overbought nor oversold. The STOCH value of 47.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:TARSONS.

Tarsons Products Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
GRMOVER	65 Neutral	₹28.62B	38.77	―	―	-8.29%	4.70%
HUHTAMAKI	64 Neutral	₹12.33B	13.53	―	0.95%	-1.59%	-75.34%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
STOVEKRAFT	61 Neutral	₹15.75B	114.54	―	0.50%	7.89%	32.07%
ICEMAKE	58 Neutral	₹11.19B	216.68	―	0.28%	33.81%	-39.04%
TARSONS	55 Neutral	₹9.70B	61.62	―	0.86%	14.37%	-40.47%